Primary small bowel adenocarcinoma: a single centre evaluation of survival
详细信息 查看全文
- 作者：S.A. Carnazzo ; G.M. Laurentini ; M.A. Fasone ; L. Samperisi
- 关键词：Immunosuppressants ; Inflammatory bowel disease
- 刊名：Digestive and Liver Disease
- 出版年：2004
- 出版时间：November 2004
- 年：2004
- 卷：36
- 期：11
- 页码：782-783
- 全文大小：24 K
文摘
The introduction and rapid diffusion of biological agents in the treatment of inflammatory bowel disease had led us to believe that the old immunosuppressive drugs were destined to disappear. However, despite a decade of clinical experience in the use of biological agents, the old immunosuppressive drugs continue to play a pivotal role in the management of inflammatory bowel disease. Various factors may account for this change of view.
Aim of the present review was to summarise key information currently available regarding the use of immunosuppressive drugs in the treatment of inflammatory bowel disease.